HEADER TRANSFERASE 27-NOV-22 8HKO TITLE MUTATED HUMAN ADP-RIBOSYLTRANSFERASE 2 (PARP2) CATALYTIC DOMAIN BOUND TITLE 2 TO RUCAPARIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PARP-2,HPARP-2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE COMPND 5 2,ARTD2,DNA ADP-RIBOSYLTRANSFERASE PARP2,NAD(+) ADP- COMPND 6 RIBOSYLTRANSFERASE 2,ADPRT-2,POLY[ADP-RIBOSE] SYNTHASE 2,PADPRT-2, COMPND 7 PROTEIN POLY-ADP-RIBOSYLTRANSFERASE PARP2; COMPND 8 EC: 2.4.2.30,2.4.2.-; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP2, ADPRT2, ADPRTL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DNA ADP-RIBOSYLTRANSFERASE 2, PARP2, RUCAPARIB, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.Y.WANG,J.ZHOU,B.L.XU REVDAT 1 01-MAY-24 8HKO 0 JRNL AUTH X.Y.WANG,J.ZHOU,B.L.XU JRNL TITL MUTATED HUMAN ADP-RIBOSYLTRANSFERASE 2 (PARP2) CATALYTIC JRNL TITL 2 DOMAIN BOUND TO RUCAPARIB JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.65 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 37871 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1887 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.6500 - 4.9300 0.99 2804 156 0.1946 0.2258 REMARK 3 2 4.9300 - 3.9200 1.00 2797 145 0.1455 0.1700 REMARK 3 3 3.9200 - 3.4200 1.00 2773 151 0.1449 0.1883 REMARK 3 4 3.4200 - 3.1100 1.00 2773 146 0.1516 0.1901 REMARK 3 5 3.1100 - 2.8900 1.00 2770 126 0.1646 0.2350 REMARK 3 6 2.8900 - 2.7200 1.00 2766 155 0.1624 0.2156 REMARK 3 7 2.7200 - 2.5800 1.00 2760 158 0.1609 0.2081 REMARK 3 8 2.5800 - 2.4700 1.00 2745 142 0.1654 0.2261 REMARK 3 9 2.4700 - 2.3700 1.00 2784 120 0.1690 0.2293 REMARK 3 10 2.3700 - 2.2900 1.00 2772 148 0.1671 0.2505 REMARK 3 11 2.2900 - 2.2200 1.00 2759 125 0.1768 0.2412 REMARK 3 12 2.2200 - 2.1600 1.00 2770 159 0.1784 0.2362 REMARK 3 13 2.1600 - 2.1000 1.00 2711 156 0.1892 0.2638 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.222 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.082 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.34 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 5806 REMARK 3 ANGLE : 1.417 7832 REMARK 3 CHIRALITY : 0.078 844 REMARK 3 PLANARITY : 0.024 1008 REMARK 3 DIHEDRAL : 15.827 2198 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HKO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 07-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1300033795. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37874 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 36.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: ALPHAFOLD MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG-3350, 0.1 M TRIS-HCL PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.14300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 396 O HOH A 701 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 259 11.98 85.92 REMARK 500 GLU A 350 -60.46 1.60 REMARK 500 ARG A 351 135.53 76.94 REMARK 500 HIS A 394 58.43 -98.79 REMARK 500 SER A 525 -39.41 -39.66 REMARK 500 GLN B 352 -85.78 -8.94 REMARK 500 HIS B 394 61.71 -101.90 REMARK 500 ASP B 543 90.58 -65.96 REMARK 500 ASP B 550 121.47 -23.58 REMARK 500 THR B 553 -36.21 90.90 REMARK 500 ARG B 570 -42.03 -130.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 351 0.11 SIDE CHAIN REMARK 500 ARG B 351 0.24 SIDE CHAIN REMARK 500 ARG B 570 0.29 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 8HKO A 230 581 UNP Q9UGN5 PARP2_HUMAN 230 581 DBREF 8HKO B 230 581 UNP Q9UGN5 PARP2_HUMAN 230 581 SEQADV 8HKO GLY A 229 UNP Q9UGN5 EXPRESSION TAG SEQADV 8HKO SER A 349 UNP Q9UGN5 THR 349 ENGINEERED MUTATION SEQADV 8HKO ARG A 351 UNP Q9UGN5 LEU 351 ENGINEERED MUTATION SEQADV 8HKO GLY A 353 UNP Q9UGN5 SER 353 ENGINEERED MUTATION SEQADV 8HKO LEU A 354 UNP Q9UGN5 PRO 354 ENGINEERED MUTATION SEQADV 8HKO GLY B 229 UNP Q9UGN5 EXPRESSION TAG SEQADV 8HKO SER B 349 UNP Q9UGN5 THR 349 ENGINEERED MUTATION SEQADV 8HKO ARG B 351 UNP Q9UGN5 LEU 351 ENGINEERED MUTATION SEQADV 8HKO GLY B 353 UNP Q9UGN5 SER 353 ENGINEERED MUTATION SEQADV 8HKO LEU B 354 UNP Q9UGN5 PRO 354 ENGINEERED MUTATION SEQRES 1 A 353 GLY PRO GLU SER GLN LEU ASP LEU ARG VAL GLN GLU LEU SEQRES 2 A 353 ILE LYS LEU ILE CYS ASN VAL GLN ALA MET GLU GLU MET SEQRES 3 A 353 MET MET GLU MET LYS TYR ASN THR LYS LYS ALA PRO LEU SEQRES 4 A 353 GLY LYS LEU THR VAL ALA GLN ILE LYS ALA GLY TYR GLN SEQRES 5 A 353 SER LEU LYS LYS ILE GLU ASP CYS ILE ARG ALA GLY GLN SEQRES 6 A 353 HIS GLY ARG ALA LEU MET GLU ALA CYS ASN GLU PHE TYR SEQRES 7 A 353 THR ARG ILE PRO HIS ASP PHE GLY LEU ARG THR PRO PRO SEQRES 8 A 353 LEU ILE ARG THR GLN LYS GLU LEU SER GLU LYS ILE GLN SEQRES 9 A 353 LEU LEU GLU ALA LEU GLY ASP ILE GLU ILE ALA ILE LYS SEQRES 10 A 353 LEU VAL LYS SER GLU ARG GLN GLY LEU GLU HIS PRO LEU SEQRES 11 A 353 ASP GLN HIS TYR ARG ASN LEU HIS CYS ALA LEU ARG PRO SEQRES 12 A 353 LEU ASP HIS GLU SER TYR GLU PHE LYS VAL ILE SER GLN SEQRES 13 A 353 TYR LEU GLN SER THR HIS ALA PRO THR HIS SER ASP TYR SEQRES 14 A 353 THR MET THR LEU LEU ASP LEU PHE GLU VAL GLU LYS ASP SEQRES 15 A 353 GLY GLU LYS GLU ALA PHE ARG GLU ASP LEU HIS ASN ARG SEQRES 16 A 353 MET LEU LEU TRP HIS GLY SER ARG MET SER ASN TRP VAL SEQRES 17 A 353 GLY ILE LEU SER HIS GLY LEU ARG ILE ALA PRO PRO GLU SEQRES 18 A 353 ALA PRO ILE THR GLY TYR MET PHE GLY LYS GLY ILE TYR SEQRES 19 A 353 PHE ALA ASP MET SER SER LYS SER ALA ASN TYR CYS PHE SEQRES 20 A 353 ALA SER ARG LEU LYS ASN THR GLY LEU LEU LEU LEU SER SEQRES 21 A 353 GLU VAL ALA LEU GLY GLN CYS ASN GLU LEU LEU GLU ALA SEQRES 22 A 353 ASN PRO LYS ALA GLU GLY LEU LEU GLN GLY LYS HIS SER SEQRES 23 A 353 THR LYS GLY LEU GLY LYS MET ALA PRO SER SER ALA HIS SEQRES 24 A 353 PHE VAL THR LEU ASN GLY SER THR VAL PRO LEU GLY PRO SEQRES 25 A 353 ALA SER ASP THR GLY ILE LEU ASN PRO ASP GLY TYR THR SEQRES 26 A 353 LEU ASN TYR ASN GLU TYR ILE VAL TYR ASN PRO ASN GLN SEQRES 27 A 353 VAL ARG MET ARG TYR LEU LEU LYS VAL GLN PHE ASN PHE SEQRES 28 A 353 LEU GLN SEQRES 1 B 353 GLY PRO GLU SER GLN LEU ASP LEU ARG VAL GLN GLU LEU SEQRES 2 B 353 ILE LYS LEU ILE CYS ASN VAL GLN ALA MET GLU GLU MET SEQRES 3 B 353 MET MET GLU MET LYS TYR ASN THR LYS LYS ALA PRO LEU SEQRES 4 B 353 GLY LYS LEU THR VAL ALA GLN ILE LYS ALA GLY TYR GLN SEQRES 5 B 353 SER LEU LYS LYS ILE GLU ASP CYS ILE ARG ALA GLY GLN SEQRES 6 B 353 HIS GLY ARG ALA LEU MET GLU ALA CYS ASN GLU PHE TYR SEQRES 7 B 353 THR ARG ILE PRO HIS ASP PHE GLY LEU ARG THR PRO PRO SEQRES 8 B 353 LEU ILE ARG THR GLN LYS GLU LEU SER GLU LYS ILE GLN SEQRES 9 B 353 LEU LEU GLU ALA LEU GLY ASP ILE GLU ILE ALA ILE LYS SEQRES 10 B 353 LEU VAL LYS SER GLU ARG GLN GLY LEU GLU HIS PRO LEU SEQRES 11 B 353 ASP GLN HIS TYR ARG ASN LEU HIS CYS ALA LEU ARG PRO SEQRES 12 B 353 LEU ASP HIS GLU SER TYR GLU PHE LYS VAL ILE SER GLN SEQRES 13 B 353 TYR LEU GLN SER THR HIS ALA PRO THR HIS SER ASP TYR SEQRES 14 B 353 THR MET THR LEU LEU ASP LEU PHE GLU VAL GLU LYS ASP SEQRES 15 B 353 GLY GLU LYS GLU ALA PHE ARG GLU ASP LEU HIS ASN ARG SEQRES 16 B 353 MET LEU LEU TRP HIS GLY SER ARG MET SER ASN TRP VAL SEQRES 17 B 353 GLY ILE LEU SER HIS GLY LEU ARG ILE ALA PRO PRO GLU SEQRES 18 B 353 ALA PRO ILE THR GLY TYR MET PHE GLY LYS GLY ILE TYR SEQRES 19 B 353 PHE ALA ASP MET SER SER LYS SER ALA ASN TYR CYS PHE SEQRES 20 B 353 ALA SER ARG LEU LYS ASN THR GLY LEU LEU LEU LEU SER SEQRES 21 B 353 GLU VAL ALA LEU GLY GLN CYS ASN GLU LEU LEU GLU ALA SEQRES 22 B 353 ASN PRO LYS ALA GLU GLY LEU LEU GLN GLY LYS HIS SER SEQRES 23 B 353 THR LYS GLY LEU GLY LYS MET ALA PRO SER SER ALA HIS SEQRES 24 B 353 PHE VAL THR LEU ASN GLY SER THR VAL PRO LEU GLY PRO SEQRES 25 B 353 ALA SER ASP THR GLY ILE LEU ASN PRO ASP GLY TYR THR SEQRES 26 B 353 LEU ASN TYR ASN GLU TYR ILE VAL TYR ASN PRO ASN GLN SEQRES 27 B 353 VAL ARG MET ARG TYR LEU LEU LYS VAL GLN PHE ASN PHE SEQRES 28 B 353 LEU GLN HET GOL A 601 6 HET GOL A 602 6 HET GOL A 603 6 HET GOL A 604 6 HET GOL A 605 6 HET RPB A 606 24 HET GOL B 601 6 HET RPB B 602 24 HETNAM GOL GLYCEROL HETNAM RPB RUCAPARIB HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 6(C3 H8 O3) FORMUL 8 RPB 2(C19 H18 F N3 O) FORMUL 11 HOH *592(H2 O) HELIX 1 AA1 ASP A 235 CYS A 246 1 12 HELIX 2 AA2 ASN A 247 MET A 258 1 12 HELIX 3 AA3 PRO A 266 LEU A 270 5 5 HELIX 4 AA4 THR A 271 ALA A 291 1 21 HELIX 5 AA5 GLY A 295 ILE A 309 1 15 HELIX 6 AA6 THR A 323 LYS A 348 1 26 HELIX 7 AA7 HIS A 356 HIS A 366 1 11 HELIX 8 AA8 SER A 376 THR A 389 1 14 HELIX 9 AA9 GLY A 411 PHE A 416 1 6 HELIX 10 AB1 ARG A 431 SER A 433 5 3 HELIX 11 AB2 ASN A 434 GLY A 442 1 9 HELIX 12 AB3 PRO A 451 TYR A 455 5 5 HELIX 13 AB4 MET A 466 ASN A 472 1 7 HELIX 14 AB5 TYR A 473 PHE A 475 5 3 HELIX 15 AB6 LYS A 504 LEU A 509 5 6 HELIX 16 AB7 SER A 525 PHE A 528 5 4 HELIX 17 AB8 ASN A 563 ASN A 565 5 3 HELIX 18 AB9 ASP B 235 CYS B 246 1 12 HELIX 19 AC1 ASN B 247 MET B 258 1 12 HELIX 20 AC2 PRO B 266 LEU B 270 5 5 HELIX 21 AC3 THR B 271 ALA B 291 1 21 HELIX 22 AC4 GLY B 295 ILE B 309 1 15 HELIX 23 AC5 THR B 323 LYS B 348 1 26 HELIX 24 AC6 HIS B 356 HIS B 366 1 11 HELIX 25 AC7 SER B 376 THR B 389 1 14 HELIX 26 AC8 GLY B 411 PHE B 416 1 6 HELIX 27 AC9 ARG B 431 SER B 433 5 3 HELIX 28 AD1 ASN B 434 GLY B 442 1 9 HELIX 29 AD2 PRO B 451 TYR B 455 5 5 HELIX 30 AD3 MET B 466 ASN B 472 1 7 HELIX 31 AD4 TYR B 473 PHE B 475 5 3 HELIX 32 AD5 LYS B 504 LEU B 509 5 6 HELIX 33 AD6 SER B 525 PHE B 528 5 4 HELIX 34 AD7 ASN B 563 ASN B 565 5 3 SHEET 1 AA1 5 CYS A 367 PRO A 371 0 SHEET 2 AA1 5 TYR A 397 LYS A 409 -1 O GLU A 406 N ARG A 370 SHEET 3 AA1 5 VAL A 567 PHE A 579 -1 O ARG A 570 N VAL A 407 SHEET 4 AA1 5 THR A 482 ALA A 491 -1 N LEU A 485 O LEU A 573 SHEET 5 AA1 5 ARG A 423 GLY A 429 -1 N HIS A 428 O LEU A 486 SHEET 1 AA2 4 ILE A 461 PHE A 463 0 SHEET 2 AA2 4 GLU A 558 VAL A 561 -1 O VAL A 561 N ILE A 461 SHEET 3 AA2 4 SER A 514 GLY A 517 -1 N THR A 515 O ILE A 560 SHEET 4 AA2 4 CYS A 495 LEU A 498 1 N ASN A 496 O SER A 514 SHEET 1 AA3 3 ALA A 541 ASP A 543 0 SHEET 2 AA3 3 GLY A 519 PRO A 523 -1 N ALA A 522 O SER A 542 SHEET 3 AA3 3 LEU A 554 TYR A 556 1 O ASN A 555 N MET A 521 SHEET 1 AA4 2 VAL A 529 LEU A 531 0 SHEET 2 AA4 2 SER A 534 VAL A 536 -1 O VAL A 536 N VAL A 529 SHEET 1 AA5 5 CYS B 367 PRO B 371 0 SHEET 2 AA5 5 THR B 398 LYS B 409 -1 O GLU B 406 N ARG B 370 SHEET 3 AA5 5 VAL B 567 ASN B 578 -1 O LYS B 574 N ASP B 403 SHEET 4 AA5 5 THR B 482 ALA B 491 -1 N LEU B 485 O LEU B 573 SHEET 5 AA5 5 ARG B 423 SER B 430 -1 N MET B 424 O VAL B 490 SHEET 1 AA6 4 ILE B 461 PHE B 463 0 SHEET 2 AA6 4 GLU B 558 VAL B 561 -1 O VAL B 561 N ILE B 461 SHEET 3 AA6 4 SER B 514 GLY B 517 -1 N GLY B 517 O GLU B 558 SHEET 4 AA6 4 CYS B 495 LEU B 498 1 N ASN B 496 O LYS B 516 SHEET 1 AA7 2 MET B 521 PRO B 523 0 SHEET 2 AA7 2 ALA B 541 ASP B 543 -1 O SER B 542 N ALA B 522 SHEET 1 AA8 2 VAL B 529 LEU B 531 0 SHEET 2 AA8 2 SER B 534 VAL B 536 -1 O VAL B 536 N VAL B 529 CISPEP 1 GLY A 539 PRO A 540 0 8.87 CISPEP 2 GLY B 539 PRO B 540 0 5.57 CRYST1 39.761 86.286 96.047 90.00 90.39 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025150 0.000000 0.000171 0.00000 SCALE2 0.000000 0.011589 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010412 0.00000